2021 RESULT OF ANNUAL GENERAL MEETING – ALL RESOLUTIONS PASSED28th June 2021 - 1:26 pm
ImmuPharma PLC (LSE:IMM | Euronext Growth Brussels: ALIMM), the specialist drug discovery and development company, held its AGM earlier today, in accordance with COVID-19 guidance. The Company is pleased to announce that all resolutions were duly passed.
The results of each resolution were as follows:
As at the date of the AGM, the number of issued ordinary shares of the Company was 250,221,297 shares, which was the total number of shares entitling the holders to attend and vote for or against all resolutions. In accordance with the Company’s Articles of Association, every member has one vote for every share held. Votes withheld are not votes in law and have not been counted in the calculation of the proportion of vote “for” or “against” a resolution. Proxy appointments which gave discretion to the Chairman have been included in the “for” total.
To download announcement click here